These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9808493)

  • 1. Examination of the sensitivity of T cells to Fas ligation: induction of allospecific apoptosis.
    O'Flaherty E; Ali S; Pettit SJ; Kirby JA
    Transplantation; 1998 Oct; 66(8):1067-73. PubMed ID: 9808493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.
    O'Flaherty E; Wong WK; Pettit SJ; Seymour K; Ali S; Kirby JA
    Immunology; 2000 Jul; 100(3):289-99. PubMed ID: 10929050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway.
    Nalbant A; Zadeh HH
    Oral Microbiol Immunol; 2002 Oct; 17(5):277-84. PubMed ID: 12354208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4. FasL induces alloantigen-specific hyporesponsiveness.
    Elhalel MD; Huang JH; Schmidt W; Rachmilewitz J; Tykocinski ML
    J Immunol; 2003 Jun; 170(12):5842-50. PubMed ID: 12794109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
    Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
    Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
    Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
    Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.
    Schütz C; Hoves S; Halbritter D; Zhang HG; Mountz JD; Fleck M
    Immunology; 2011 May; 133(1):115-22. PubMed ID: 21342185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Fas-Fas ligand interactions in graft rejection.
    Martinez OM; Krams SM
    Int Rev Immunol; 1999; 18(5-6):527-46. PubMed ID: 10672500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
    Uzzo RG; Rayman P; Kolenko V; Clark PE; Bloom T; Ward AM; Molto L; Tannenbaum C; Worford LJ; Bukowski R; Tubbs R; Hsi ED; Bander NH; Novick AC; Finke JH
    Clin Cancer Res; 1999 May; 5(5):1219-29. PubMed ID: 10353760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
    Yu XZ; Anasetti C
    Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens.
    Van Parijs L; Peterson DA; Abbas AK
    Immunity; 1998 Feb; 8(2):265-74. PubMed ID: 9492007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in chronic rejection of human cardiac allografts.
    Xu B; Sakkas LI; Slachta CA; Goldman BI; Jeevanandam V; Oleszak EL; Platsoucas CD
    Transplantation; 2001 Apr; 71(8):1137-46. PubMed ID: 11374416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
    Srivastava RK; Sasaki CY; Hardwick JM; Longo DL
    J Exp Med; 1999 Jul; 190(2):253-65. PubMed ID: 10432288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent apoptosis induced by low concentrations of methylmercury in murine splenic Fas+ T cell subsets.
    Pheng S; Chakrabarti S; Lamontagne L
    Toxicology; 2000 Aug; 149(2-3):115-28. PubMed ID: 10967409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing.
    Suda T; Hashimoto H; Tanaka M; Ochi T; Nagata S
    J Exp Med; 1997 Dec; 186(12):2045-50. PubMed ID: 9396774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte apoptosis is increased by non-interleukin-2-dependent induction in human mixed lymphocyte cultures.
    Woodside KJ; Hu M; Gugliuzza KK; Hunter GC; Daller JA
    Transplant Proc; 2005 May; 37(4):1949-52. PubMed ID: 15919515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.